AARTI PHARMALABS
Quarterly Results Analysis [Mar2025]
AARTI PHARMALABS Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹564 Cr | ₹538 Cr | ₹458 Cr | ₹555 Cr | ₹506 Cr | ₹449 Cr | ₹440 Cr | ₹458 Cr |
Expenses | ₹418 Cr | ₹409 Cr | ₹364 Cr | ₹459 Cr | ₹388 Cr | ₹353 Cr | ₹352 Cr | ₹373 Cr |
Operating Income | ₹146 Cr | ₹129 Cr | ₹94 Cr | ₹96 Cr | ₹118 Cr | ₹96 Cr | ₹88 Cr | ₹85 Cr |
Other Income | ₹-2 Cr | ₹5 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹7 Cr | ₹10 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Depreciation | ₹23 Cr | ₹23 Cr | ₹21 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹18 Cr | ₹17 Cr |
Profit Before Tax | ₹115 Cr | ₹101 Cr | ₹72 Cr | ₹74 Cr | ₹96 Cr | ₹74 Cr | ₹67 Cr | ₹64 Cr |
Profit After Tax | ₹88 Cr | ₹74 Cr | ₹55 Cr | ₹55 Cr | ₹65 Cr | ₹53 Cr | ₹52 Cr | ₹47 Cr |
EPS | ₹9.75 | ₹8.16 | ₹6.03 | ₹6.12 | ₹7.20 | ₹5.82 | ₹5.72 | ₹5.20 |
Industry Peers & Returns | 1W | 1M | 1Y |
AARTI PHARMALABS | 3.5% | 27.6% | 55% |
SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -8.3% | 15.9% |
DIVIS LABORATORIES | -1.9% | 8.6% | 55.9% |
CIPLA | -1.3% | -5.5% | -0.1% |
TORRENT PHARMACEUTICALS | -0.5% | -4.2% | 19.3% |
DR REDDYS LABORATORIES | 0.7% | 5.8% | 6.1% |
MANKIND PHARMA | 1.8% | 0.4% | 16.6% |
ZYDUS LIFESCIENCES | 1.9% | 4.8% | -12.7% |
LUPIN | -1.5% | -6.5% | 21.9% |
AARTI PHARMALABS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.83 % |
Y-o-Y | 11.47 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹564 Cr | 4.83 | |
Dec2024 | ₹538 Cr | 17.41 | |
Sep2024 | ₹458 Cr | -17.55 | |
Jun2024 | ₹555 Cr | 9.83 | |
Mar2024 | ₹506 Cr | 12.72 | |
Dec2023 | ₹449 Cr | 2.02 | |
Sep2023 | ₹440 Cr | -4.05 | |
Jun2023 | ₹458 Cr | - |
AARTI PHARMALABS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 13.23 % |
Y-o-Y | 23.92 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹146 Cr | 13.23 | |
Dec2024 | ₹129 Cr | 37.29 | |
Sep2024 | ₹94 Cr | -2.89 | |
Jun2024 | ₹96 Cr | -17.92 | |
Mar2024 | ₹118 Cr | 22.82 | |
Dec2023 | ₹96 Cr | 8.74 | |
Sep2023 | ₹88 Cr | 3.68 | |
Jun2023 | ₹85 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 8.03 % |
Y-o-Y | 11.19 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 25.83% | 8.03 | |
Dec2024 | 23.91% | 16.92 | |
Sep2024 | 20.45% | 17.80 | |
Jun2024 | 17.36% | -25.27 | |
Mar2024 | 23.23% | 8.96 | |
Dec2023 | 21.32% | 6.55 | |
Sep2023 | 20.01% | 8.05 | |
Jun2023 | 18.52% | - |
AARTI PHARMALABS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 19.40 % |
Y-o-Y | 35.39 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹88 Cr | 19.40 | |
Dec2024 | ₹74 Cr | 35.45 | |
Sep2024 | ₹55 Cr | -1.50 | |
Jun2024 | ₹55 Cr | -15.01 | |
Mar2024 | ₹65 Cr | 23.66 | |
Dec2023 | ₹53 Cr | 1.86 | |
Sep2023 | ₹52 Cr | 10.00 | |
Jun2023 | ₹47 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 13.88 % |
Y-o-Y | 21.47 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 15.67 % | 13.88 | |
Dec2024 | 13.76 % | 15.34 | |
Sep2024 | 11.93 % | 19.54 | |
Jun2024 | 9.98 % | -22.64 | |
Mar2024 | 12.9 % | 9.69 | |
Dec2023 | 11.76 % | -0.17 | |
Sep2023 | 11.78 % | 14.70 | |
Jun2023 | 10.27 % | - |
AARTI PHARMALABS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 19.49 % |
Y-o-Y | 35.42 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹9.75 | 19.49 | |
Dec2024 | ₹8.16 | 35.32 | |
Sep2024 | ₹6.03 | -1.47 | |
Jun2024 | ₹6.12 | -15.00 | |
Mar2024 | ₹7.2 | 23.71 | |
Dec2023 | ₹5.82 | 1.75 | |
Sep2023 | ₹5.72 | 10.00 | |
Jun2023 | ₹5.2 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD